Menstrual Cycle Phase Based Training
MCPBT
Investigating the Effects of Menstrual Cycle Phase Based Training on Muscle Strength and Hypertrophy
1 other identifier
interventional
24
1 country
1
Brief Summary
The primary purpose of this study is to employ state-of-the-art methods to fill current knowledge gaps on the effects of the menstrual cycle on resistance exercise training adaptations. This work will reduce the sex gap present in exercise physiology, improving women's health information by yielding a deeper understanding of the effect of female physiology on exercise adaptations and subsequent health benefits. Employing a unilateral training design, participant's will have their legs randomized to one of four groups: non-exercise control (CON), exercise control (EX), Follicular based training (FOL), Luteal based training (LUT) Researchers will compare these conditions to see if there are greater benefits to prioritizing resistance training around phases of the menstrual cycle,
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedAugust 22, 2025
August 1, 2025
1.2 years
June 22, 2023
August 18, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Muscle Hypertrophy
The investigators will be measuring participant's muscle cross-sectional area of the quadriceps pre and post training intervention via ultrasound (US) US is used to measure skeletal muscle thickness and cross-sectional area. A trained and experienced study investigator will perform the US measures. US will be used to measure the cross-sectional area of the vastus lateralis muscle on both legs. After remaining supine for 15-minute, your feet will be positioned in a custom foot-hold apparatus that prevents depression of the thigh against the bed. Mid-thigh will be identified via palpation. A marker will be used to draw a line down your leg, perpendicular to the surface of the bed, and horizontal markings will be made every 2 cm serving as a guideline for ultrasound probe placement. Ultrasound images will be taken at each horizontal marking and used to measure the muscle cross-sectional area of the quadriceps.
16 weeks
Muscular Strength
The investigators will be measuring participant's muscle strength via one-repetition maximum testing using the unilateral leg press.
16 Weeks
Study Arms (4)
Non-Exercise Control (CON)
ACTIVE COMPARATORThis condition will serve as a non-exercise control and will not be performing resistance exercise training (RET)
Follicular Based Training (FOL)
EXPERIMENTALThis condition will have high volume of RET (20 weekly sets) during the follicular phase and low volume during the luteal phase of the participant's menstrual cycle.
Luteal Based Training (LUT)
EXPERIMENTALThis condition will have high volume of RET (20 weekly sets) during the luteal phase and low volume during the follicular phase of the participant's menstrual cycle.
Exercise Control (EX)
EXPERIMENTALThis condition will have consistent training volume (12 weekly sets) throughout the duration of the study, regardless of what phase of the menstrual cycle the participant is in.
Interventions
One will perform unilateral resistance exercise
Eligibility Criteria
You may qualify if:
- Women, between the ages of 18 - 30 years (inclusive)
- Have a body mass index (BMI) between 18-35 kg·m2 (inclusive)
- Be in general good health as assessed by a general health questionnaire
- Non-smoking
- Regular menstrual cycle (21-35 days, inclusive)
- Not using hormonal contraceptives
- Willing and able to provide informed consent
You may not qualify if:
- Use of tobacco or related products.
- Ineligible to participate in physical activity based on get active questionnaire (GAQ)
- Any concurrent medical, orthopedic, or psychiatric condition that, in the opinion of the Investigator, would compromise his/her ability to comply with the study requirements.
- Current illnesses which could interfere with the study (e.g. prolonged severe diarrhea, regurgitation, difficulty swallowing)
- Use of hormonal contraceptives
- Currently pregnant
- Training more than 3x/week for the past 6 months.
- Have any electronic medical or metal implants
- A history of neuromuscular disorders or muscle/bone wasting diseases
- The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.)
- A (family) history of thrombosis
- The use of anticoagulant medications
- Excessive alcohol consumption (\>21 units/wk)
- History of bleeding diathesis, platelet or coagulation disorders, or antiplatelet/anticoagulation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Metabolism Research Laboratory, McMaster Univeristy
Hamilton, Ontario, L8S 4K1, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- As this is a resistance exercise training intervention, participants will be unable to be masked to their treatment condition.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 7, 2023
Study Start
September 1, 2023
Primary Completion
November 15, 2024
Study Completion
November 30, 2024
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
All participants will be assigned a unique subject identification number (ID), and therefore, other researchers involved with analyses will not have access to identifying participant information.